Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Metagenomi Therapeutics Inc banner
M

Metagenomi Therapeutics Inc
NASDAQ:MGX

Watchlist Manager
Metagenomi Therapeutics Inc
NASDAQ:MGX
Watchlist
Price: 1.15 USD
Market Cap: $43.3m
Write Note Create Alert Ask AI

DCF Value

The DCF Value for Metagenomi Therapeutics Inc (MGX) under the Base Case is hidden USD. Compared with the current market price of 1.15 USD, the stock appears hidden .

Key assumptions
MGX DCF Value
LOCKED
Unlock

DCF Model

DCF Assumptions
Revenue Growth -18.5%
Net Margin -1 606.6%-677.9%
Cash Flow Conversion 100%
Forecast Period 5 years
Model Settings
Template via FCFE
Discount Rate 9.6%
Terminal Growth 0%
Valuation Result
DCF Value per Share
LOCKED
Unlock
·
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Continue MGX Research

Summary
MGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
MGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MGX stock valuation using valuation multiples.
Wall St Estimates
MGX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
ALPHA SPREAD
Follow us
Join 359,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.